Estradiol/Norgestimate (Prefest) Side Effects: What to Expect and When to Call Your Doctor

Like all hormone replacement therapy products, Estradiol/Norgestimate (Prefest) comes with a profile of potential side effects — ranging from mild and manageable to rare but serious. Understanding what to expect helps you stay on your therapy confidently and recognize warning signs that require prompt medical attention. This guide covers both the common and serious side effects of Prefest in plain language.

Common Side Effects of Prefest (Estradiol/Norgestimate)

These side effects are relatively common, especially when first starting Prefest. Many improve or resolve within 1–3 months as your body adjusts to the hormonal changes:

• Nausea: Can occur, especially when starting treatment. Taking Prefest with food may help reduce nausea.
• Breast tenderness or pain: Common with estrogen-containing therapies. Usually improves after a few weeks. Report any new lumps or masses to your provider promptly.
• Breakthrough bleeding or spotting: Irregular vaginal bleeding is one of the most common side effects with any HRT regimen, especially in the first 3–6 months. Prefest's intermittent progestogen cycle may cause some cyclic bleeding patterns. Persistent or heavy bleeding should be evaluated.
• Headache: Mild headaches are common in early treatment. If you experience severe headaches or migraines, contact your doctor.
• Abdominal bloating and cramping: Fluid retention and gastrointestinal changes can cause bloating in some patients.
• Vaginal discharge: Changes in vaginal discharge can occur with HRT. Contact your provider if discharge is accompanied by itching, odor, or other unusual features.
• Mood changes: Some patients notice mood changes — positive or negative — when starting HRT. These often stabilize as hormones equilibrate.
• Fluid retention and weight changes: Estrogen can cause mild fluid retention in some patients.

Serious Side Effects: Call Your Doctor Right Away

These side effects are less common but potentially serious. Seek medical attention immediately if you experience any of the following:

• Signs of a blood clot (DVT or PE): Leg swelling, pain, or warmth in one leg; sudden chest pain; shortness of breath; coughing blood. Estrogen-progestin therapy increases the risk of blood clots — this is a medical emergency.
• Signs of a stroke: Sudden numbness or weakness on one side of the body, sudden severe headache, trouble speaking, vision changes, or difficulty walking. Call 911 immediately.
• Signs of a heart attack: Chest pain or pressure, pain radiating to jaw, arm, or back, nausea, or sweating. Seek emergency care immediately.
• Unusual vaginal bleeding: Any unexpected or heavy vaginal bleeding in a postmenopausal woman requires evaluation. It can be a sign of endometrial hyperplasia or cancer, particularly with prolonged estrogen use.
• New breast lump: Combined estrogen-progestin therapy is associated with a modest increased risk of breast cancer, especially with long-term use. Report any breast lumps, nipple discharge, or skin changes immediately.
• Liver problems: Jaundice (yellowing of skin or eyes), severe abdominal pain, or dark urine can indicate liver dysfunction. Report these symptoms promptly.
• Gallbladder symptoms: Estrogen can increase cholesterol in bile, raising the risk of gallstones. Upper-right abdominal pain, fever, or nausea after eating fatty meals can indicate gallbladder problems.
• Vision changes: Sudden changes in vision, visual disturbances, or loss of vision should be evaluated promptly. These can be signs of a vascular event.

Boxed Warning: What Prefest Carries

Prefest carries an FDA boxed warning (the strongest level of drug warning) for the following risks:

• Cardiovascular disease: Estrogen-progestin combination therapy should not be used to prevent heart disease.
• Breast cancer: Combined estrogen-progestin therapy increases the risk of breast cancer. The risk increases with duration of use.
• Endometrial cancer: Unopposed estrogen increases endometrial cancer risk. The progestin in Prefest significantly reduces, but does not eliminate, this risk.
• Probable dementia: A study in women 65+ found increased risk of dementia with combined estrogen-progestin therapy. It is unclear if this applies to younger women starting HRT close to menopause onset.

How to Minimize Side Effect Risk

Your prescriber can help minimize side effect risk by:

• Using the lowest effective dose for the shortest time needed to control your symptoms.
• Reviewing your treatment every 3–6 months to determine if continued therapy is necessary.
• Performing annual mammograms and regular breast self-exams.
• Reporting any unusual vaginal bleeding immediately.

The Bottom Line

Most patients tolerate Prefest (Estradiol/Norgestimate) well, and the majority of common side effects — such as nausea, breast tenderness, and breakthrough bleeding — improve over the first few months of therapy. However, it's important to recognize the warning signs of serious complications and report them to your doctor promptly. For information about drug interactions that could affect Prefest's safety, see our guide on Estradiol/Norgestimate drug interactions.